# Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery

> **NCT02819908** · PHASE4 · COMPLETED · sponsor: **Eye Center of North Florida** · enrollment: 25 (actual)

## Conditions studied

- Intraocular Lens Associated Postoperative Inflammation

## Interventions

- **DRUG:** Imprimis Dropless
- **DRUG:** Imprimis Less Drops

## Key facts

- **NCT ID:** NCT02819908
- **Lead sponsor:** Eye Center of North Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02819908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02819908, "Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02819908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*